Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants [Phase 1]

View source ↗

Summary

An AstraZeneca Phase 1 study evaluated the pharmacokinetics, safety, and tolerability of AZD4144 in participants with severe renal impairment, end-stage kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• AZD4144

Snippet

Sponsor: AstraZeneca | Conditions: Renal Impairment, End-stage Kidney Disease | Phase 1 | Status: COMPLETED